Severine Guillen Selected Research

BIM 23268

1/2006

Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Severine Guillen Research Topics

Disease

1	Neoplasms (Cancer) 01/2006
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2006
1	Prolactinoma (Prolactinomas) 01/2006
1	Growth Hormone-Secreting Pituitary Adenoma 01/2006

Drug/Important Bio-Agent (IBA)

1	BIM 23268IBA 01/2006
1	pasireotideIBA 01/2006
1	TBR-760IBA 01/2006
1	Cabergoline FDA LinkGeneric 01/2006
1	Dopamine (Intropin)FDA LinkGeneric 01/2006
1	LigandsIBA 01/2006
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2006
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2006
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2006
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2006